Lyon, France – 12 April 2023 – 6pm CEST – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases and pioneer in the development of drug... | April 12, 2023

Related Keywords

Paris ,France General ,France ,Chicago ,Illinois ,United States ,French ,Worldsymposium Orlando ,Marco Sardiello ,Inserm Transfert ,Mathieu Charv ,Emyr Lloyd Evans ,Claude Bernard Lyon ,Research Association ,Cardiff University United Kingdom ,Baylor College Of Medicine Houston ,Translational Research Conference For The Management ,Atomic Energy Commission ,Research Tax Credit ,French National Institute Of Health ,Federation Of European Neurosciences Societies ,Research Inserm ,Franck Mouthon ,European Neurosciences Societies ,Batten Disease Support ,Healthcare Conference ,Baylor College ,Cardiff University ,United Kingdom ,Translational Research Conference ,French National Institute ,Medical Research ,Hospices Civils De Lyon ,French Alternative Energies ,Euronext Growth ,Theranexus Stock Exchange ,News ,Information ,Press Release ,2 ,Pril ,023 ,Pm ,Pest ,Iopharmaceutical ,Company ,Innovating ,N ,The ,Treatment ,F ,Mare ,Neurological ,Diseases ,End ,Pioneer ,Development ,F Althx Fr0013286259 ,